The Efficacy of HDR Brachytherapy for Patients with Recurrent or Margin-Positive Post-Operative Basal Cell Carcinoma

Surgery is a standard treatment for patients suffering from non-melanoma skin cancer. However, postoperative relapse or positive margins after surgery are linked with worse outcome. We aimed to analyze surface high-dose-rate brachytherapy as an adjuvant/salvage option.